title: Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation.
authors.affiliation: Department of Anaesthesia and Intensive Care, King's College Hospital, Denmark Hill, London, England.
authors.forename: S
authors.initials: S
authors.lastname: Cottam
authors.forename: B
authors.initials: B
authors.lastname: Hunt
authors.forename: H
authors.initials: H
authors.lastname: Segal
authors.forename: R
authors.initials: R
authors.lastname: Ginsburg
authors.forename: D
authors.initials: D
authors.lastname: Potter
mesh_terms: D007611:Aprotinin / Q000627:therapeutic use*; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D016031:Liver Transplantation / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000378:metabolism; D000979:alpha-2-Antiplasmin / Q000378:metabolism
chemical_list: D000979:alpha-2-Antiplasmin; D007611:Aprotinin; D010959:Tissue Plasminogen Activator